Helo Corp.
HLOC
Other OTC0.04
USD
- -
- -
ISIN
US42349A1097
CUSIP
42349A109
Return %
Stock
S&P500
1Y
-77.69
18.86
3Y
-85.12
64.57
5Y
-96.75
71.65
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Seán McVeigh
- Full Time Employees
- 1
- Sector
- Technology
- Industry
- Consumer Electronics
- Address
- 180 Steuart Street San Francisco CA United States of America 94119
- IPO Date
- Jan 4, 2016
- Website
- helocorp.com
- Similar Companies
- Business
- Helo Corp. (OTC: HLOC) develops and markets data-driven wellness technology, focusing on wearable devices and related applications that deliver health insights through self-tracking in the quantified-self market. Founded in 2010 and headquartered in San Francisco, California, the company offers products built on its proprietary Life Sensing Technology, which employs advanced sensors, signal processing, and algorithms to monitor biometric parameters including heart rate, blood pressure estimation, breath rate, energy levels, mood, sleep, body fat percentage, visceral fat, muscle mass, bone mass, ECG, atrial fibrillation detection, SpO2, sleep apnea, body temperature, fall detection, and vascular aging; its core wearable lineup includes VYVO Vista, VYVO Sense smartband with 6-axis movement and ECG sensor, VYVO Icon smartwatch, VYVO Leggera smart scale for body composition metrics, VYVO Vista+, VYVO Watch Lite, VYVO Watch Lite SE, and VYVO Watch Generation 2, with historical models such as Helo Classic, Helo LX series, and Helo Extense; complementary offerings feature the NutraMatic AI-enabled countertop device for real-time personalized nutrition delivery based on wearable biodata and urinalysis, integrated with Helo AI for ongoing optimization, and the forthcoming BioSense Watch launching in Q2 2025 with embedded air quality sensors for TVOC and CO2 detection plus Life CoPilot AI OS for personalized wellness guidance. Helo Corp. operates globally through marketing and distribution partner VYVO HK Ltd. and its network, targeting health-conscious consumers via direct sales, promoters, and Big Data platforms for research and monetization; Helo Health serves as a key subsidiary advancing the global health and wellness wearable market. Recent developments include the announcement of NutraMatic pre-launch in spring 2025 with prioritized access and the NutraLife AI Program international study for biomarker data training, preparations for BioSense Watch market entry following operational restructuring, a 2023 blockchain agreement with Vyvo Smart Chain Ltd. and VSC Tech Pte. Ltd. to enable user data control and monetization via $5 million licensing including Premier Foundation Sponsor status, and an ongoing Asia launch partnership with Vyvo SocialFi for NutraMatic rollout at events like the Okinawa Premier Workshop.
Helo Corp Prepares Market Launch of BioSense Watch with embedded AI Life CoPilot and Air Sensor
Helo Corp Announces Annual 2023 Results
Helo Corp. Exhibiting at the Las Vegas Moneyshow®, February 21 – 23, 2024
Helo Corp to Present at Emerging Growth Conference on January 11, 2024
Helo Corp Announces NutraMatic To Provide AI-Personalized Nutrition
Helo Corp Announces Third Quarter Results and Emerging Growth Conference Presentation
7 OTC Stocks That Made It Big in 2021 for Multiple Reasons